Alcon's latest marketcap:
As of 06/22/2025, Alcon's market capitalization has reached $42.58 B. According to our data, Alcon is the 506th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 42.58 B |
| Revenue (ttm) | 9.92 B |
| Net Income (ttm) | 1.12 B |
| Shares Out | 495.7 M |
| EPS (ttm) | 2.25 |
| Forward PE | 26.22 |
| Ex-Dividend Date | 05/13/2025 |
| Earnings Date | 08/19/2025 |
Alcon's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/22/2025 | $42.58 B | -0.08% | 506 |
| 12/30/2024 | $41.93 B | 9.07% | 463 |
| 12/29/2023 | $38.45 B | 14.43% | 469 |
| 12/30/2022 | $33.6 B | -22.39% | 496 |
| 12/30/2021 | $43.29 B | 30.98% | 450 |
| 12/30/2020 | $33.05 B | 527 |
Company Profile
About Alcon Inc.
Alcon Inc. is a global leader in eye care, specializing in the research, development, manufacturing, and distribution of innovative products for surgical and vision care needs. Headquartered in Geneva, Switzerland, the company has been dedicated to improving eye health since its founding in 1945.
Business Segments
Alcon operates through two primary segments:
- Surgical: Focuses on advanced equipment, diagnostics, and implantables for eye surgeries.
- Vision Care: Provides contact lenses and ocular health products for everyday eye care.
Key Products & Solutions
Surgical Segment
- Cataract Solutions: Includes the Centurion vision system, LenSx laser system, Verion digital marker, and a range of intraocular lenses (IOLs).
- Vitreoretinal Products: Features the Constellation vision system, vitrectomy probes, and precision surgical instruments.
- Refractive Surgery: Offers WaveLight and Contoura Vision technologies for LASIK procedures.
Vision Care Segment
- Contact Lenses: Daily disposable, reusable, and color-enhancing options.
- Ocular Health: Products for dry eye, allergies, glaucoma, and contact lens care, as well as vitamins and redness relievers.
Company Background
Originally established as Alcon Universal S.A., the company rebranded as Alcon Inc. in 2001. With decades of expertise, Alcon continues to drive innovation in eye care, helping millions of people worldwide achieve better vision.
Frequently Asked Questions
-
What is Alcon's (ALC) current market cap?As of 06/22/2025, Alcon (including the parent company, if applicable) has an estimated market capitalization of $42.58 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Alcon (ALC) rank globally by market cap?Alcon global market capitalization ranking is approximately 506 as of 06/22/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.